A borderline correlation was noted between the expression of bFGF and its receptor (P=0.067): 87.5% of the patients who expressed bFGF in their lymphomas, also expressed FGFR-1, compared to only 50% of the patients who's lymphomas did not express bFGF. This evidence concerns the gene FGF2 and lymphoma.